NCT01649648.

Study name	Autologous cord blood cells for brain injury in term newborns
Methods	Phase 1, open‐label, single group assignment study
Participants	Estimated sample size = 10 Inclusion criteria Autologous umbilical cord blood available > 36 weeks' gestation Brain injury that satisfies criteria for therapeutic hypothermia Parental informed consent
Interventions	Autologous cord blood infusion
Outcomes	Primary outcome: adverse event rates occurring in the recipients within the 3 first days of life. Secondary outcomes Neurodevelopmental assessment (Peabody tests, Bayley Scales of Infant Development) with time frame 1 month to 2 years MRI brain at 1 to 2 weeks old and 4 to 6 months old (kind of analysis is not defined)
Starting date	September 2011
Contact information	Principal Investigator: Jiun Lee, MBBS, National University Hospital, Singapore Principal Investigator: Samuel Rajadurai, MBBS, KK Women's and Children's Hospital Principal Investigator: Cheo Lian Yeo, MBBS, Singapore General Hospital
Notes	Study sponsor:  National University Hospital, Singapore